Literature DB >> 8191168

[Anti-reflux surgery: indications, principles and contribution of laparoscopy].

G B Cadière1.   

Abstract

Surgery is indicated when gastro-oesophageal reflux disease (GORD) is resistant to medical treatment. Manometry, upper GI series, pH-metry, gastric emptying studies and gastric acid sampling are performed in order to demonstrate that GORD is caused by a deficient gastro-oesophageal valve mechanism, and hence that surgical treatment will be beneficial. The surgical principle is restoring an anti-reflux barrier by recreating a sufficient pressure gradient in the distal oesophagus, and by correcting the gastro-oesophageal Hiss. Nissen' fundoplication is probably the most efficient anti-reflux procedure. However, it can cause dysphagia, gas bloating and inability to burp. One hundred and fifty-six laparoscopic Nissen fundoplications have been performed by the author. Operating time average 120 min. No perioperative death was observed. There were 3 conversions to laparotomy and 4 peroperative complications: 1 gastric perforation, 2 lesions of the pleura and 1 liver laceration. Four postoperative complications occurred: 1 pneumonia, 1 necrosis of the wrap, 1 small bowel perforation and 1 obstruction due to migration of the entire stomach into the chest. Hospitalisation time ranged between 2 and 14 days (median 2), with a follow up of a median of 10 months. Long-term postoperative complications were: 1 recurrent heartburn 6 months postoperatively and 2 severe dysphagia.

Entities:  

Mesh:

Year:  1994        PMID: 8191168

Source DB:  PubMed          Journal:  Rev Med Brux        ISSN: 0035-3639


  2 in total

Review 1.  Complications of laparoscopic antireflux surgery.

Authors:  D I Watson; A C de Beaux
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

2.  A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time?

Authors:  D I Watson; R J Baigrie; G G Jamieson
Journal:  Ann Surg       Date:  1996-08       Impact factor: 12.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.